Patents Assigned to Kremers-Urban Company
  • Patent number: 5334395
    Abstract: A therapeutic method for treating Epstein-Barr virus infection. The method comprises administering a therapeutically-effective amount of a mammalian liver extract, the extract being characterized by being heat stable, insoluble in acetone and soluble in water, peptide or peptide fragment selected from the groups consisting of Sequence Identification Numbers 1-9.
    Type: Grant
    Filed: August 24, 1992
    Date of Patent: August 2, 1994
    Assignee: Kremers-Urban Company
    Inventors: Sudhakar S. Wagle, Thomas Steinbach, Carl H. Lawyer, William J. Hermann, Jr., Ali A. S. Gawish
  • Patent number: 5316775
    Abstract: A therapeutic method for treating hepatitis B infection. The method comprises administering a therapeutically-effective amount of a mammalian liver extract, the extract being characterized by being heat stable, insoluble in acetone and soluble in water, peptide or peptide fragment selected from the groups consisting of Sequence Identification Numbers 1-9.
    Type: Grant
    Filed: April 19, 1993
    Date of Patent: May 31, 1994
    Assignee: Kremers-Urban Company
    Inventors: Sudhakar S. Wagle, Thomas Steinbach, Carl H. Lawyer, William J. Hermann, Jr., Ali A. S. Gawish
  • Patent number: 5284664
    Abstract: A therapeutic method for treating Alzheimer's or related disease. The method comprises administering a therapeutically-effective amount of a mammalian liver extract, the extract being characterized by being heat stable, insoluble in acetone and soluble in water, peptide or peptide fragment selected from the groups consisting of Sequence Identification Numbers 1-9.
    Type: Grant
    Filed: February 5, 1992
    Date of Patent: February 8, 1994
    Assignee: Kremers-Urban Company
    Inventors: Sudhakar S. Wagle, Thomas Steinbach, Carl H. Lawyer, William J. Hermann, Ali A. S. Gawish
  • Patent number: 3979508
    Abstract: The stereo-isomeric penicilloyl-polylysine conjugates having high optical dextro-rotations are useful for eliciting cutaneous responses in persons with penicillin hypersensitivity.The process for manufacturing the above-entitled stereo-specific conjugates reacts penicillin with neutralized polylysine hydrochloride in a non-aqueous polar solvent such as dimethyl sulfoxide.
    Type: Grant
    Filed: January 10, 1975
    Date of Patent: September 7, 1976
    Assignee: Kremers-Urban Company
    Inventors: Mark A. Stahmann, Sudhakar S. Wagle